Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Gut
|
March 1, 1995
Ascitic fluid gamma interferon concentrations and adenosine deaminase activity in tuberculous peritonitis
M A Sathar, A E Simjee, Y M Coovadia, et al.
Journal of Medical Virology
|
May 1, 1993
Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus
P N Soni, D R Tait, D G Kenoyer, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
December 3, 1988
Incidence of Campylobacter pylori in patients with upper gastro-intestinal symptoms
N M Miller, A Naran, A E Simjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2004
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis
David S Krause, A E Simjee, Christo van Rensburg, et al.
The Journal of Infectious Diseases
|
September 1, 1990
Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica
J I Ravdin, T F Jackson, W A Petri, et al.
Alimentary Pharmacology & Therapeutics
|
September 1, 1999
Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up
C J Van Rensburg, P J Honiball, J H Van Zyl, et al.
Alimentary Pharmacology & Therapeutics
|
November 9, 2000
Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa
B C Wong, F Y Chang, S Abid, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 1996
Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis
C J van Rensburg, P J Honiball, H D Grundling, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Gut
|
March 1, 1995
Ascitic fluid gamma interferon concentrations and adenosine deaminase activity in tuberculous peritonitis
M A Sathar, A E Simjee, Y M Coovadia, et al.
Journal of Medical Virology
|
May 1, 1993
Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus
P N Soni, D R Tait, D G Kenoyer, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
December 3, 1988
Incidence of Campylobacter pylori in patients with upper gastro-intestinal symptoms
N M Miller, A Naran, A E Simjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 9, 2004
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis
David S Krause, A E Simjee, Christo van Rensburg, et al.
The Journal of Infectious Diseases
|
September 1, 1990
Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica
J I Ravdin, T F Jackson, W A Petri, et al.
Alimentary Pharmacology & Therapeutics
|
September 1, 1999
Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up
C J Van Rensburg, P J Honiball, J H Van Zyl, et al.
Alimentary Pharmacology & Therapeutics
|
November 9, 2000
Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa
B C Wong, F Y Chang, S Abid, et al.
Alimentary Pharmacology & Therapeutics
|
June 1, 1996
Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis
C J van Rensburg, P J Honiball, H D Grundling, et al.
Page
of 6